Literature DB >> 17182106

Plasma testosterone and dehydroepiandrosterone sulfate in male and female patients with dysthymic disorder.

Manolis Markianos1, John Tripodianakis, Democritos Sarantidis, John Hatzimanolis.   

Abstract

BACKGROUND: Depressive symptomatology has been connected with an activation of the hypothalamus-pituitary-adrenal axis and, in several studies, with reduced androgen levels, while administration of androgens, usually in older subjects, may have positive effects on mood, both in males and females. Regarding dysthymic disorder (DD), low serum testosterone levels have been reported in older males, while information on younger male or on female patients is lacking.
METHODS: We assessed the serum levels of testosterone (T), dehydroepiandrosterone sulfate (DHEAS) and cortisol in male and female patients with DD, and compared them to the levels of sex and age matched controls. Eighteen male and 43 female patients in the age range of 22 to 71 years were studied and diagnosed according to the Scheduled Diagnostic Interview for DSM-IV axis I disorders (SCID). Depressive symptomatology was assessed using the Hamilton Depression Rating Scale. Subgroups with subjects below or over 50 years of age were also built and compared.
RESULTS: Serum T levels were lower than controls mainly in the subjects aged below 50 years, in both genders. More pronounced were reductions in DHEAS levels both in male and female patients, while cortisol levels were normal or reduced. T levels were positively correlated to both DHEAS and cortisol. The negative correlations of DHEAS and T to age were significant for all groups and subgroups, except in the group of male patients. Four male patients (22%) had T levels below 2.0 ng/ml.
CONCLUSIONS: Male and female patients with DD aged below 50 years show reduced gonadal and adrenal androgen levels, and normal to low cortisol levels. These neuroendocrine characteristics differentiate DD from depression, and place this diagnostic group closer to posttraumatic stress disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182106     DOI: 10.1016/j.jad.2006.11.013

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

1.  Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).

Authors:  Joyce T Bromberger; Laura L Schott; Howard M Kravitz; Maryfran Sowers; Nancy E Avis; Ellen B Gold; John F Randolph; Karen A Matthews
Journal:  Arch Gen Psychiatry       Date:  2010-06

2.  An association analysis between psychophysical characteristics and genome-wide gene expression changes in human adaptation to the extreme climate at the Antarctic Dome Argus.

Authors:  C Xu; X Ju; D Song; F Huang; D Tang; Z Zou; C Zhang; T Joshi; L Jia; W Xu; K-F Xu; Q Wang; Y Xiong; Z Guo; X Chen; F Huang; J Xu; Y Zhong; Y Zhu; Y Peng; L Wang; X Zhang; R Jiang; D Li; T Jiang; D Xu; C Jiang
Journal:  Mol Psychiatry       Date:  2014-09-09       Impact factor: 15.992

Review 3.  Chronic depression: update on classification and treatment.

Authors:  Dana C Torpey; Daniel N Klein
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

Review 4.  Risks and benefits of testosterone therapy in older men.

Authors:  Matthew Spitzer; Grace Huang; Shehzad Basaria; Thomas G Travison; Shalender Bhasin
Journal:  Nat Rev Endocrinol       Date:  2013-04-16       Impact factor: 43.330

Review 5.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606

6.  Relationship between testosterone levels and depressive symptoms in older men in Amirkola, Iran.

Authors:  Farzan Kheirkhah; Seyed Reza Hosseini; Seyyedeh Fatemeh Hosseini; Nafiseh Ghasemi; Ali Bijani; Robert G Cumming
Journal:  Caspian J Intern Med       Date:  2014

7.  Neurosteroid Levels in Patients with Obsessive-Compulsive Disorder.

Authors:  Lale Gonenir Erbay; Sukru Kartalci
Journal:  Psychiatry Investig       Date:  2015-09-30       Impact factor: 2.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.